The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
Open accessAbstract
Drug-induced severe cutaneous adverse reactions (SCARs) include acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS), and epidermal necrolysis (Stevens-Johnson syndrome [SJS], toxic epidermal necrolysis). The identification of the causal drug is crucial in order to avoid further exposure, but making the right differential diagnosis of the type of SCAR is equally important since treatment, follow-up, and prognosis of different SCARs are not the same. These syndromes are distinct entities with different clinical, biological, and histological patterns, but sometimes the early distinction between 2 SCARs can be extremely challenging, and overlapping conditions could therefore be taken into consideration, although true overlapping SCARs are very rare when using strict diagnostic criteria (described by the RegiSCAR group). Only a better understanding of the physiopathology of the SCARs could possibly explain these ambiguities and overlaps. We report a case of SCAR in an 86-year-old patient probably induced by allopurinol and simultaneously fulfilling the diagnostic criteria for DRESS and SJS, thus considered as an overlapping case of SCARs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
Fouchard, N., Bertocchi, M., Roujeau, J.-C., Revuz, J., Wolkenstein, P., & Bastuji-Garin, S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00061.x · Cited by 1,199
Kardaun, S. H., Sidoroff, A., Valeyrie-Allanore, L., Halevy, S., Davidovici, B. B., Mockenhaupt, M., & Roujeau, J. C. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07704.x · Cited by 934
Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction pattern
Sidoroff, A., Halevy, S., Bavinck, J. N. B., Vaillant, L., & Roujeau, J. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.028003113.x · Cited by 818
Husain, Z., Reddy, B. Y., & Schwartz, R. A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.033 · Cited by 489
Halevy, S., Ghislain, P.-D., Mockenhaupt, M., Fagot, J.-P., Bouwes Bavinck, J. N., Sidoroff, A., Naldi, L., Dunant, A., Viboud, C., & Roujeau, J.-C. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.036 · Cited by 479
Schwartz, R. A., McDonough, P. H., & Lee, B. W. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.05.002 · Cited by 338
Schwartz, R. A., McDonough, P. H., & Lee, B. W. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.05.003 · Cited by 316
Tangamornsuksan, W., Chaiyakunapruk, N., Somkrua, R., Lohitnavy, M., & Tassaneeyakul, W. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.4114 · Cited by 263
Life-threatening acute adverse cutaneous drug reactions
Wolf, R., Orion, E., Marcos, B., & Matz, H. (2005) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.06.012 · Cited by 175
Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS)
Descamps, V., Ben Saïd, B., Sassolas, B., Truchetet, F., Avenel-Audran, M., Girardin, P., Guinnepain, M.-T., Mathelier-Fusade, P., Assier, H., Milpied, B., et al. (2010) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2010.04.024 · Cited by 161
Research works printed but not linked: 3
- 10.1186/1750-1172-7-72 · doi:10.1186/1750-1172-7-72
- 10.5021/ad.2016.28.1.98 · doi:10.5021/ad.2016.28.1.98
- 10.1111/bjd.14451 · doi:10.1111/bjd.14451
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
The DRESS Syndrome: A Literature Review
Cacoub, P., Musette, P., Descamps, V., Meyer, O., Speirs, C., Finzi, L., & Roujeau, J. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.017 · Cited by 1,012
Kardaun, S. H., Sekula, P., Valeyrie-Allanore, L., Liss, Y., Chu, C. Y., Creamer, D., Sidoroff, A., Naldi, L., Mockenhaupt, M., Roujeau, J. C., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12501 · Cited by 1,010
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J. J., Kasperavičiūtė, D., Carrington, M., Sills, G. J., Marson, T., Jia, X., de Bakker, P. I. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013297 · Cited by 925
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Gout: An old disease in new perspective – A review
Ragab, G., Elshahaly, M., & Bardin, T. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.04.008 · Cited by 599
Husain, Z., Reddy, B. Y., & Schwartz, R. A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.033 · Cited by 489
Severe cutaneous adverse reactions to drugs
Duong, T. A., Valeyrie-Allanore, L., Wolkenstein, P., & Chosidow, O. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30378-6 · Cited by 445
Idiosyncratic Adverse Reactions to Antiepileptic Drugs
Zaccara, G., Franciotta, D., & Perucca, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01041.x · Cited by 364
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Lerch, M., Mainetti, C., Terziroli Beretta-Piccoli, B., & Harr, T. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8654-z · Cited by 355
Drug Reaction With Eosinophilia and Systemic Symptoms: A Retrospective Study of 60 Cases
Chen, Y.-C., Chiu, H.-C., & Chu, C.-Y. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.198 · Cited by 350
Zimmermann, S., Sekula, P., Venhoff, M., Motschall, E., Knaus, J., Schumacher, M., & Mockenhaupt, M. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.5668 · Cited by 328
Husain, Z., Reddy, B. Y., & Schwartz, R. A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.032 · Cited by 328
Physiology of Hyperuricemia and Urate-Lowering Treatments
Benn, C. L., Dua, P., Gurrell, R., Loudon, P., Pike, A., Storer, R. I., & Vangjeli, C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00160 · Cited by 319
Shiohara, T., & Mizukawa, Y. (2019) · Allergology International · doi:10.1016/j.alit.2019.03.006 · Cited by 318
Idiosyncratic Adverse Drug Reactions: Current Concepts
Uetrecht, J., & Naisbitt, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007450 · Cited by 310
Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
Chung, W.-H., Chang, W.-C., Lee, Y.-S., Wu, Y.-Y., Yang, C.-H., Ho, H.-C., Chen, M.-J., Lin, J.-Y., Hui, R. C.-Y., Ho, J.-C., et al. (2014) · JAMA · doi:10.1001/jama.2014.7859 · Cited by 297
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions
Wang, C.-W., Yang, L.-Y., Chen, C.-B., Ho, H.-C., Hung, S.-I., Yang, C.-H., Chang, C.-J., Su, S.-C., Hui, R. C.-Y., Chin, S.-W., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93349 · Cited by 289
Cho, Y.-T., Yang, C.-W., & Chu, C.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061243 · Cited by 286
Drug induced liver injury: an update
Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M. I., & Andrade, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02885-1 · Cited by 286
Genin, E., Chen, D.-P., Hung, S.-I., Sekula, P., Schumacher, M., Chang, P.-Y., Tsai, S.-H., Wu, T.-L., Bellón, T., Tamouza, R., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.40 · Cited by 257
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study
Dibek Misirlioglu, E., Guvenir, H., Bahceci, S., Haktanir Abul, M., Can, D., Usta Guc, B. E., Erkocoğlu, M., Toyran, M., Nacaroglu, H. T., Civelek, E., et al. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.02.013 · Cited by 96
Haskamp, S., Bruns, H., Hahn, M., Hoffmann, M., Gregor, A., Löhr, S., Hahn, J., Schauer, C., Ringer, M., Flamann, C., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.07.001 · Cited by 84
Current perspectives on severe drug eruption
Zhang, J., Lei, Z., Xu, C., Zhao, J., & Kang, X. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08859-0 · Cited by 60
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Miyazu, D., Kodama, N., Yamashita, D., Tanaka, H., Inoue, S., Imakyure, O., Hirakawa, M., Shuto, H., & Kataoka, Y. (2016) · American Journal of Case Reports · doi:10.12659/ajcr.899149 · Cited by 27
Safety profile of etifoxine: A French pharmacovigilance survey
Cottin, J., Gouraud, A., Jean‐Pastor, M., Dautriche, A. D., Boulay, C., Geniaux, H., Auffret, M., Bernard, N., Descotes, J., & Vial, T. (2016) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12169 · Cited by 22
Hasty generalizations and generics in medical research: A systematic review
Peters, U., Sherling, H. R., & Chin-Yee, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0306749 · Cited by 11
Metadata
- Authors
- Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V.
- Venue
- Case Reports in Dermatology
- Publisher
- S. Karger AG
- Published
- 2017-05-08
- Volume
- 9
- Issue
- 2
- Pages
- 1-7
- ISSN
- 1662-6567 (ISSN-L)
- OpenAlex
- W4319053765
- Cited by
- 1,466
- References
- 12
- FWCI
- 79.14
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.